A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Video Testimonials Barbara, 74 74-year-old MMTC patient Barbara gives her experience as a medical cannabis user and a nurse
Positioned within the high-cost segment of diabetes and obesity care, these treatments face affordability challenges that directly affect patient uptake and adherence
Inching Closer to a NASH Cure: Daily Semaglutide Achieves Resolution of NASH but Not Fibrosis after 72 Weeks Not Fibrosis after 72 Weeks Sonali Paul, MD, MS Associate Professor of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Chicago Medicine, Center for Liver Disease, Chicago, Illinois This article reviews Newsome PN, et al
Tavares, M
The distinction matters for the conversation with a provider: the label reflects absent evidence, not demonstrated injury, though absent evidence is still a reason for caution
